Advances in the diagnosis and treatment of pulmonary tuberculosis complicated with diabetes

doi:10.3969/j.issn.1000-6621.2019.12.015

Abstract

Abstract:

Tuberculosis is still a major global health problem. In recent years, increasing evidence has demonstrated that diabetes increases the risk of tuberculosis infection, and tuberculosis complicated with diabetes can lead to adverse outcomes of tuberculosis, which brings great difficulties and challenges to the prevention and control of tuberculosis. By reviewing the latest epidemiological studies on tuberculosis complicated with diabetes in recent years, the authors expound the relationship between tuberculosis and diabetes. This paper further proves that two-way screening is beneficial to the early detection and treatment of diseases, and then summarizes the research progress in the diagnosis and treatment of tuberculosis complicated with diabetes, which is aimed to search for the optimal diagnosis and treatment methods and explore novel ideas for diagnosis and treatment.

Key words: Tuberculosis,pulmonary, Diabetes mellitus, Comorbidity, Multiphasic screening, Combined modality therapy, Review literature as topic

Yi MAO,Lin FAN,Yong LIU. Advances in the diagnosis and treatment of pulmonary tuberculosis complicated with diabetes[J]. Chinese Journal of Antituberculosis, 2019, 41(12): 1325-1329. doi: 10.3969/j.issn.1000-6621.2019.12.015

References 51

[1]	World Health Organization. Global tuberculosis report 2018. Geneva: World Health Organization, 2018.
[2]	Chatterjee S, Khunti K, Davies MJ . Type 2 diabetes. Lancet, 2017,389(10085):2239-2251.
[3]	Gao HX, Regier EE, Close KL . International Diabetes Federation World Diabetes Congress 2015. J Diabetes, 2016,8(3):300-302.
[4]	桂徐蔚, 沙巍 . 肺结核合并糖尿病研究进展. 中国实用内科杂志, 2015,35(8):657-659.
[5]	Al-Rifai RH, Pearson F, Critchley JA , et al. Association between diabetes mellitus and active tuberculosis: a systematic review and meta-analysis. PLoS One, 2017,12(11):e0187967.
[6]	Grint D, Alisjhabana B, Ugarte-Gil C , et al. Accuracy of diabetes screening methods used for people with tuberculosis, Indonesia, Peru, Romania, South Africa. Bull World Health Organ, 2018,96(11):738-749.
[7]	Pande T, Huddart S, Xavier W , et al. Prevalence of diabetes mellitus amongst hospitalized tuberculosis patients at an Indian tertiary care center: A descriptive analysis. PLoS One, 2018,13(7):e0200838.
[8]	McMurry HS, Mendenhall E, Rajendrakumar A , et al. Copre-valence of type 2 diabetes mellitus and tuberculosis in low-income and middle-income countries: A systematic review. Diabetes Metab Res Rev, 2019,35(1):e3066.
[9]	Lee MR, Huang YP, Kuo YT , et al. Diabetes mellitus and latent tuberculosis infection: a systemic review and metaanalysis. Clin Infect Dis, 2017,64(6):719-727.
[10]	Pan SC, Ku CC, Kao D , et al. Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study. Lancet Diabetes Endocrinol, 2015,3(5):323-330.
[11]	Ali MK, Magee MJ, Dave JA , et al. HIV and metabolic, body, and bone disorders: what we know from low- and middle-income countries. J Acquir Immune Defic Syndr, 2014,67 Suppl 1: S27-S39.
[12]	Pizzol D, Di Gennaro F, Chhaganlal KD , et al. Tuberculosis and diabetes: current state and future perspectives. Trop Med Int Health, 2016,21(6):694-702.
[13]	Restrepo BI, Schlesinger LS . Impact of diabetes on the natural history of tuberculosis. Diabetes Res Clin Pract, 2014,106(2):191-199.
[14]	Viswanathan V, Vigneswari A, Selvan K , et al. Effect of diabetes on treatment outcome of smear-positive pulmonary tuberculosis-a report from South India. J Diabetes Complications, 2014,28(2):162-165.
[15]	王燕森, 赵延吉, 万康林 , 等. 糖尿病合并初治涂阳肺结核患者痰茵阴转的影响因素研究. 中国防痨杂志, 2015,37(12):1236-1239. doi: 10.3969/j.issn.1000-6621.2015.12.014 URL
[16]	Rifat M, Milton AH, Hall J , et al. Development of multidrug resistant tuberculosis in Bangladesh: a casecontrol study on risk factors. PLoS One, 2014,9(8):e105214.
[17]	Tegegne BS, Mengesha MM, Teferra AA , et al. Association between diabetes mellitus and multi-drug-resistant tuberculosis: evidence from a systematic review and meta-analysis. Syst Rev, 2018,7(1):161.
[18]	Yoon YS, Jung JW, Jeon EJ , et al. The effect of diabetes control status on treatment response in pulmonary tuberculosis: a prospective study. Thorax, 2017,72(3):263-270.
[19]	World Health Organization. Collaborative Framework for Care and Control of Tuberculosis and Diabetes. Geneva:World Health Organization, 2011.
[20]	Boillat-Blanco N, Ramaiya KL, Mganga M , et al. Transient hyperglycemia inpatients with tuberculosis in Tanzania: implications for diabetes screening algorithms. J Infect Dis, 2016,213(7):1163-1172.
[21]	Ogbera AO, Kapur A, Chinenye S , et al. Undiagnosed diabetes mellitus in tuberculosis: A Lagos report. Indian J Endocrinol Metab, 2014,18(4):475-479.
[22]	Gupte AN, Mave V, Meshram S , et al. Trends in HbA1c levels and implications for diabetes screening in tuberculosis cases undergoing treatment in India. Int J Tuberc Lung Dis, 2018,22(7):800-806.
[23]	Pande T, Cohen C, Pai M , et al. Computer-aided detection of pulmonary tuberculosis on digital chest radiographs: a systema-tic review. Int J Tuberc Lung Dis, 2016,20(9):1226-1230.
[24]	Koesoemadinata RC, Kranzer K, Livia R , et al. Computer-assisted chest radiography reading for tuberculosis screening in people living with diabetes mellitus. Int J Tuberc Lung Dis, 2018,22(9):1088-1094.
[25]	Pal R, Ansari MA, Hameed S , et al. Diabetes Mellitus as Hub for Tuberculosis Infection: A Snapshot. Int J Chronic Dis, 2016,2016:5981574.
[26]	Dong Z, Shi J, Dorhoi A , et al. Hemostasis and Lipoprotein Indices Signify Exacerbated Lung Injury in TB With Diabetes Comorbidity. Chest, 2018,153(5):1187-1200.
[27]	Nguyen DT, Graviss EA . Development and validation of a risk score to predict mortality during TB treatment in patients with TB-diabetes comorbidity. BMC Infect Dis, 2019,19(1):10.
[28]	李华, 陈效友 . 结核病及其相关疾病. 中华结核和呼吸杂志, 2014,34(7):552-555.
[29]	Huang LK, Wang HH, Lai YC , et al. The impact of glycemic status on radiological manifestations of pulmonary tuberculosis in diabetic patients. PLoS One, 2017,12(6):e0179750.
[30]	Magee MJ, Kempker RR, Kipiani M , et al. Diabetes Melli-tUS,Smoking Status,and Rate of Sputum Cuhure Conversion in Patients with Muhidrug-Resistant Tuberculosis:A Cohort Study from the Country of Georgia. PLoS One, 2014,9(4):e94890.
[31]	Shin HJ, Kim TO, Oh HJ , et al. Impact of diabetes mellitus on indeterminate results of the QuantiFERON TB Gold In-Tube test:A propensity score matching analysis. PLoS One, 2017,12(7):e0181887.
[32]	余亚丽, 刘红, 位亚静 , 等. 结核感染T细胞斑点试验对糖尿病患者肺结核的临床诊断意义. 国际呼吸杂志, 2015,35(21):1612-1616.
[33]	王雅, 吴妹英, 杨坤云 , 等. 结核感染T细胞斑点试验在糖尿病并发肺结核诊断中的价值. 中国防痨杂志, 2018,40(8):846-853.
[34]	Aftab H, Christensen DL, Ambreen A , at al. Tuberculosis-Reabetes:Is It Reversible after Comlete Treatment? Am J Trop Med Hyg, 2017,97(4), 1099-1102.
[35]	Riza AL, Pearson F, Ugarte-Gil C , et al. Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol, 2014,2(9):740-753.
[36]	Lachmandas E, van den Heuvel CN, Damen MS , et al. Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids. J Diabetes Res, 2016,2016:6014631.
[37]	中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版). 中华糖尿病杂志, 2018,10(1):4-67.
[38]	Alfarisi O, Mave V, Gaikwad S , et al. The effect of diabetes mellitus on the pharmacokinetics and pharmacodynamics of tuberculosis treatment. Antimicrob Agents Chemother, 2018,62(11). pii:e01383-18.
[39]	宋丽, 岳峰 . 利福喷丁联合胰岛素强化降糖对糖尿病合并肺结核的疗效. 实用中西医结合临床, 2018,8(2):1-2,5.
[40]	Zumla A, Rao M, Parida SK , et al. Inflammation and tuberculosis: host-directed therapies. J Intern Med, 2015,277(4):373-387.
[41]	Ma Y, Pang Y, Shu W , et al. Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up. Eur J Clin Microbiol Infect Dis, 2018,37(7):1259-1263.
[42]	Lee YJ, Han SK, Park JH , et al. The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus. Korean J Intern Med, 2018,33(5):933-940.
[43]	Lee MC, Chiang CY, Lee CH , et al. Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria. PLoS One, 2018,13(10):e0205807.
[44]	Restrepo BI . Metformin: Candidate host-directed therapy for tuberculosis in diabetes and non-diabetes patients. Tuberculosis (Edinb), 2016,101S:S69-S72.
[45]	Lai CC, Lee MT, Lee SH , et al. Statin treatment is associated with a decreased risk of active tuberculosis: An analysis of a nationally representative cohort. Thorax, 2016,71(7):646-651.
[46]	Parihar SP, Guler R, Khutlang R , et al. Statin therapy reduces the Mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation. J Infect Dis, 2014,209(5):754-763.
[47]	Su VY, Su WJ, Yen YF , et al. Statin use is associated with a lower risk of TB. Chest, 2017,152(3):598-606.
[48]	Magee MJ, Salindri AD, Kornfeld H , et al. Reduced prevalence of latent tuberculosis infection in diabetes patients using metformin and statins. Eur Respir J , 2019,53(3). pii: 1801695.
[49]	Badawi A, Sayegh S, Sadoun E , et al. Relationship between insulin resistance and plasma vitamin D in adults. Diabetes Metab Syndr Obes, 2014,7:297-303.
[50]	Lopez-Lopez N, Gonzalez-Curiel I, Castañeda-Delgado J , et al. Vitamin D supplementation promotes macrophages anti-mycobacterial activity in type 2 diabetes mellitus patients with low vitamin D receptor expression. Microbes Infect, 2014,16(9):755-761.
[51]	Zhao X, Yuan Y, Lin Y , et al. Vitamin D status of tuberculosis patients with diabetes mellitus in different economic areas and associated factors in China. PLoS One, 2018,13(11):e0206372.